Janus kinase-1 (JAK-1)

Pipeline Summary for Products Targeting Janus kinase-1 (JAK-1)
Print this Phases of Development Preclinical Phase II Phase III Registration Approved Autoimmune 0 4 1 1 0 Cancer 1 1 0 0 0 Hematology 0 2 0 0 1 Ophthalmic 0 1 0 0 0 Transplant 0 1 0 0 0 Copyright ©2012 BioCentury Publications, Inc. All Rights Reserved